论文部分内容阅读
作者于5～7年前对47名21～30岁的卫生工作者接种Merck血源乙型肝炎疫苗20μg,0、1和6个月各接种1次,作为历史对照。重组酵母乙型肝炎疫苗亦为Merck厂所制造。按0、1和6个月对287名21～30岁血清阴性的卫生工作者作三角肌注射,其中113人接种10μg,114人接种5μg,60人接种2.5μg,并于首针后1年加强接种5μg或10μg。18名男性和13名女性于5～7年前按0、1、2和9个月接种血源疫苗、但抗-HBc及抗
Forty-seven health workers 21 to 30 years old were vaccinated with 20 μg of Merck Hepatitis B vaccine 5-7 years earlier, and were vaccinated at 0, 1, and 6 months as historical controls. Recombinant yeast Hepatitis B vaccine is also manufactured by Merck. At 0, 1, and 6 months, 287 seronegative workers aged 21 to 30 years were given deltoid injections, of whom 113 were inoculated with 10 μg, 114 with 5 μg, 60 with 2.5 μg, and one year after the first injection Strengthen vaccination 5μg or 10μg. 18 males and 13 females were vaccinated with blood-borne vaccines at 0, 1, 2, and 9 months 5-7 years earlier, but anti-HBc and anti-HBs